Kshemaka Gunawardena

Disrupting peroxisomes alters lipid metabolism in melanoma and uncovers a novel therapeutic vulnerability in combination with MAPK-targeted therapies

C. Gonçalves, J. Swinnen, A. Talebi, 2022, bioRxiv.

Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma

John J. Mitchell, J. Swinnen, A. Talebi, 2023, The Journal of clinical investigation.